Alkermes PLC.

ALKS Nasdaq Healthcare · Pharmaceutical Preparations Dublin 4, Ireland www.alkermes.com/
$46.85
Mkt Cap 7.87B

Biopharmaceutical company developing and marketing neuroscience medicines, including treatments for schizophrenia, bipolar disorder, and alcohol and opioid dependence.

—
/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$1.75B
FCF TTM
$227.3M
P/FCF
34.6x
Running full 6-factor analysis…